Pharmacology of adriamycin: The message to the clinician
- 30 April 1988
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (4) , 579-582
- https://doi.org/10.1016/0277-5379(88)90283-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4′-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissuesBiochemical Pharmacology, 1987
- The effects of adriamycin on intracellular calcium concentrations of L1210 murine leukemia cellEuropean Journal of Cancer and Clinical Oncology, 1987
- Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: Evidence from metabolites identified in serumEuropean Journal of Cancer and Clinical Oncology, 1986
- Stability of solutions of antineoplastic agents during preparation and storage for in vitro assaysCancer Chemotherapy and Pharmacology, 1986
- Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyaglycones in AKR mice bearing a sub-cutaneously growing Ridgway Osteogenic Sarcoma (ROS)European Journal of Cancer and Clinical Oncology, 1986
- Determination of anthracycline purity in patient samples and identification of in vitro chemical reduction products by application of a multi-diode array high-speed spectrophotometric detectorJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Optimal schedule for anthracyclinesEuropean Journal of Cancer and Clinical Oncology, 1985
- Pharmacokinetics of adriamycin in patients with breast cancer: Correlation between pharmacokinetic parameters and clinical short-term responseEuropean Journal of Cancer and Clinical Oncology, 1982
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978
- A fluorometric assay for daunomycin and adriamycin in animal tissuesBiochemical Medicine, 1973